Displaying 1 publication

Abstract:
Sort:
  1. Hasan M, Kumolosasi E, Jantan I, Jasamai M, Nazarudin N
    Acta Pharm, 2022 Mar 01;72(1):109-122.
    PMID: 36651527 DOI: 10.2478/acph-2022-0005
    Annexin A1 (ANXA1) is an endogenous protein involved in the control of proliferation, cell cycle, phagocytosis, and apoptosis in several types of cancer. To investigate the effects of ANXA1 knockdown in leukemia cells, transfection with specific ANXA1 siRNA was performed. Cell cycle and apoptosis were analyzed using flow cytometry and a mechanism involving caspases and Bcl-2 was quantified using Western blotting. Phagocytosis activity was evaluated using hematoxylin & eosin staining. The ANXA1 expression was significantly downregulated after the knockdown and apoptosis was induced in tested cells. The expression of caspase-9 and -3 increased in U937 and Jurkat cells respectively. Bcl-2 expression was downregulated in K562 and Jurkat cells while upregulated in U937. The number of leukemic cells arrested at the G2/M phase and the phagocytosis index were significantly increased in transfected cells. This suggests that ANXA1 knockdown might be a potential approach in the therapeutic strategy for leukemia.
    Matched MeSH terms: Proto-Oncogene Proteins c-bcl-2/pharmacology
Related Terms
Filters
Contact Us

Please provide feedback to Administrator ([email protected])

External Links